The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in small-cell lung cancer (SCLC).

被引：0
|
作者：
Kareff, Samuel A.
Krause, Harris Benjamin
Elliott, Andrew
Lopes, Gilberto
Lou, Emil
Soares, Heloisa P.
Oberley, Matthew James
Chauhan, Aman
机构：
[1] Univ Miami, Sylvester Comprehens Canc Ctr, Jackson Mem Hosp, Miami, FL USA
[2] Caris Life Sci, Irving, TX USA
[3] Caris Life Sci, Phoenix, AZ USA
[4] Univ Miami, Miami, FL USA
[5] Univ Minnesota, Minneapolis, MN USA
[6] Univ Utah Hlth, Hunstman Canc Hosp, Salt Lake City, UT USA
[7] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3128
引用
收藏
页数：1
相关论文
共 50 条
  • [31] RANDOMIZED COMPARISON OF TREATMENT DURATION IN SMALL-CELL LUNG-CANCER (SCLC)
    EARL, H
    SOUHAMI, RL
    ASH, CM
    SPIRO, SG
    GEDDES, D
    HARPER, PG
    TOBIAS, JS
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 224 - 224
  • [32] ORAL IFOSFAMIDE AND ETOPOSIDE FOR SMALL-CELL LUNG-CANCER (SCLC) PATIENTS
    CERNY, T
    THATCHER, N
    LIND, M
    CARROLL, K
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S101 - S101
  • [33] NGR-hTNF and doxorubicin in relapsed small-cell lung cancer (SCLC)
    Cavina, Raffaele
    Gregorc, Vanesa
    Novello, Silvia
    Grossi, Francesco
    Santoro, Armando
    Vigano, Maria Grazia
    Levra, Matteo G.
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Transitioning to a Personalized Approach in Molecularly Subtyped Small-Cell Lung Cancer (SCLC)
    Grenda, Anna
    Krawczyk, Pawel
    Obara, Adrian
    Gajek, Lukasz
    Lomza-Laba, Aleksandra
    Milanowski, Janusz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
  • [35] THE EFFECT OF BOMBESIN ANTAGONISTS ON THE GROWTH OF SMALL-CELL LUNG-CANCER (SCLC)
    LAYTON, JE
    SCANLON, D
    MORSTYN, G
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 32 - 32
  • [36] Targeting an ubiquitin-activating enzyme in small-cell lung cancer (SCLC)
    Majeed, Safa
    Aparnathi, Mansi K.
    Song, Lifang
    Schimmer, Aaron D.
    Tsao, Ming S.
    Liu, Geoffrey
    Lok, Benjamin H.
    CANCER RESEARCH, 2019, 79 (13)
  • [37] LONG-TERM SURVIVAL IN SMALL-CELL LUNG-CANCER (SCLC)
    BRANCACCIO, L
    CRISPINO, C
    SORRENTINO, A
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S43 - S43
  • [38] BRAIN METASTASES (BMET) AND SURVIVAL IN SMALL-CELL LUNG-CANCER (SCLC)
    GIANNONE, L
    JOHNSON, DH
    HAINSWORTH, JD
    OELTMANN, TN
    HANDE, KR
    GRECO, FA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 153 - 153
  • [39] SMALL-CELL LUNG-CANCER (SCLC) PRESENTING AS A SOLITARY PULMONARY NODULE (SPN)
    QUOIX, E
    WOLKOVE, N
    FRASER, R
    FINKELSTEIN, H
    COHEN, C
    FRANK, H
    KREISMAN, H
    CHEST, 1986, 89 (06) : S503 - S503
  • [40] PHARMACOKINETICS (PK) OF DOXORUBICIN (DOX) IN SMALL-CELL LUNG-CANCER (SCLC) PATIENTS
    PISCITELLI, SC
    RODVOLD, KA
    RUSHING, DA
    TEWKSBURY, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 145 - 145
12345